Quality of economic evaluations in health care - It is time for action to ensure higher methodological quality

被引：28

作者：

Jefferson, T ^{[1
]}

Demicheli, V

机构：

[1] Hlth Reviews Ltd, Surrey GU16 6JP, England

[2] Serv Sovrazonale Epidemiol, ASL 20, I-15100 Alessandria, Italy

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2002年 / 324卷 / 7333期

关键词：

D O I：

10.1136/bmj.324.7333.313

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：313 / 314

页数：2

相关论文

共 16 条

[1] ECONOMIC-ANALYSIS IN RANDOMIZED CONTROL TRIALS
ADAMS, ME
MCCALL, NT
GRAY, DT
ORZA, MJ
CHALMERS, TC
[J]. MEDICAL CARE, 1992, 30 (03) : 231 - 243
[2] DRUMMOND M, 1996, EC EVALUATION HEALTH
[3] Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, MF
Jefferson, TO
[J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7052) : 275 - 283
[4] EGGET M, IN PRESS JAMA
[5] Comorbidity measures for use with administrative data
Elixhauser, A
Steiner, C
Harris, DR
Coffey, RN
[J]. MEDICAL CARE, 1998, 36 (01) : 8 - 27
[6] ELIXHAUSET A, 1993, MED CARE, V31, pJ31
[7] Raising the quality of cost-utility analyses: lessons learnt and still to learn
Gerard, K
Smoker, I
Seymour, J
[J]. HEALTH POLICY, 1999, 46 (03) : 217 - 238
[8] COST-UTILITY IN PRACTICE - A POLICY MAKERS GUIDE TO THE STATE-OF-THE-ART
GERARD, K
[J]. HEALTH POLICY, 1992, 21 (03) : 249 - 279
[9] Problems with the interpretation of pharmacoeconomic analyses - A review of submissions to the Australian pharmaceutical benefits scheme
Hill, SR
Mitchell, AS
Henry, DA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16): : 2116 - 2121
[10] IS VACCINATION AGAINST HEPATITIS-B EFFICIENT - A REVIEW OF WORLD LITERATURE
JEFFERSON, T
DEMICHELI, V
[J]. HEALTH ECONOMICS, 1994, 3 (01) : 25 - 37